Newsroom ARCHIVE
Welcome to the newsroom archive
of AOP Health
Please find below archived press releases
Press Releases
Explore the archived press releases about AOP Health, its products, studies and cooperations. We will be happy to answer any questions or comments you may have via aop-health@aoporphan.com
AOP Orphan Pharmaceuticals AG announces start of EMA marketing authorization application procedure for Ropeginterferon alfa-2b in Polycythemia Vera
14. 3. 2017
AOP Orphan and PharmaEssentia announce pivotal phase III results for ropeginterferon alfa-2b in Polycythemia Vera
5. 12. 2016
AOP Orphan Pharmaceuticals AG announces European “approvable” opinion of its ultra-short acting beta blocker Rapibloc® (Landiolol)
11. 7. 2016
Roland Bindeus moves from Baxalta to AOP Health – new Head of the Hematology & Oncology Business Unit
4. 4. 2016
Suzie McFadzean – new Chief of Commercial Operations
13. 10. 2015
AOP Orphan strengthens core CNS specialty business with high promise in movement disorder treatments
19. 6. 2015